Logo
Dermaren Lumi Naju

Dermaren Lumi Naju

Dermaren

Medical Device
  • Marketed as a CE Marked medical device or sterile cosmetic/skin booster product in relevant territories, with compliance to applicable EU/UK medical device or cosmetic regulations as indicated by distributors.
  • Manufactured in facilities operating under ISO 13485 Compliant quality management systems for medical devices and in compliance with Korean MFDS and international standards for injectable aesthetic products.
  • Part of the Dermaren portfolio, which uses high Quality raw materials and is typically EDQM Grade hyaluronic acid where HA is included.
Injectable Polynucleotide & Hyaluronic Acid Skin Booster

Description

Dermaren Lumi Naju is an advanced injectable skin revitalisation treatment designed to deeply hydrate, repair and rejuvenate tired or ageing skin. This next-generation PN and HA-based skin booster combines highly purified polynucleotides (PN) with hyaluronic acid (HA) in a dual-action formula that promotes tissue regeneration while restoring long-lasting moisture balance. By stimulating cellular renewal and improving the dermal matrix, Lumi Naju enhances skin texture, tone, density and elasticity, helping to reduce fine lines and visible signs of chrono- and photoageing. Following a course of treatments, skin appears smoother, firmer, brighter and more radiant, making Lumi Naju ideal for patients seeking comprehensive skin renewal on the face, neck and décolletage. The product is supplied as a box containing three 2.5 ml pre-filled syringes for professional use in aesthetic clinics.

Bnefits

  • Combines polynucleotides (PN) and hyaluronic acid (HA) for dual skin regeneration and deep hydration.
  • Provides long-lasting moisture balance in the skin, promoting improved suppleness and comfort.
  • Improves overall skin tone, density and texture for a smoother, more refined surface.
  • Helps reduce visible signs of ageing and photoageing, including fine lines and dullness.
  • Supports natural cellular regeneration and dermal repair, enhancing structural skin quality over time.
  • Smooths fine lines while improving elasticity and firmness in treated areas.
  • Restores radiance and luminosity, giving the complexion a fresher, more youthful appearance.
  • Enhances skin brightness and vitality in key treatment areas such as the face, neck and décolletage.
  • Korean-developed injectable skin booster designed specifically for intensive biorevitalisation.

Indications

  • Professional skin biorevitalisation for tired, dull or ageing skin on the face, neck and décolletage.
  • Patients with dehydrated skin requiring deep, long-lasting hydration and improved moisture balance.
  • Improvement of skin texture, tone and density where early to moderate signs of ageing are present.
  • Reduction in the appearance of fine lines and superficial wrinkles due to loss of collagen and elasticity.
  • Supportive treatment for photoaged skin showing uneven tone, reduced radiance and mild laxity.
  • Adjunctive regenerative therapy in aesthetic practice where stimulation of cellular regeneration and dermal rebuilding is desired, as judged by a qualified practitioner.

Composition

  • Active components: Polynucleotides (PN) – highly purified regenerative nucleic acid fragments designed to stimulate cellular repair and dermal regeneration.
  • Active components: Hyaluronic acid (HA) – non-crosslinked or lightly stabilised hyaluronic acid to provide deep hydration and improve skin turgor and softness.
  • Vehicle: Sterile buffered aqueous solution with appropriate excipients and stabilisers suitable for injectable biorevitalisation products (exact quantitative composition proprietary to the manufacturer).
  • Free from added volumising crosslinked dermal filler gels; formulated as a skin booster/tissue stimulator rather than a traditional filler.

Formulation

  • Product type: Injectable skin booster / tissue stimulator for skin biorevitalisation.
  • Pharmaceutical form: Sterile, clear injectable solution in pre-filled syringes.
  • Actives: Combination of polynucleotides (PN) and hyaluronic acid (HA).
  • Volume per syringe: 2.5 ml.
  • Route of administration: Intradermal or superficial sub-dermal injection by trained medical professionals only.
  • Intended use: Professional aesthetic treatment aimed at hydration, regeneration and rejuvenation of skin.

Packaging

  • Standard presentation: Box containing 3 pre-filled syringes, each with 2.5 ml of product (3 x 2.5 ml).
  • Each syringe supplied in sterile blister packaging inside the branded outer carton.
  • Outer carton printed with product name, brand (Dermaren Lumi Naju), batch number, expiry date, storage conditions and regulatory symbols.
  • Some distributors may supply individual syringes (1 x 2.5 ml) taken from original multi-syringe packs, while maintaining original sterile primary packaging.

Usage

  • For professional use only: Dermaren Lumi Naju must be administered exclusively by suitably trained and qualified healthcare professionals experienced in injectable aesthetic treatments.
  • Before treatment, perform a full medical history, skin assessment and suitability evaluation, and obtain informed consent according to local regulations and clinic protocols.
  • Cleanse and disinfect the treatment area in accordance with standard aseptic techniques for injectable procedures.
  • Inject small amounts of product into the dermis or superficial sub-dermis of the face, neck or décolletage, following an appropriate skin-booster/mesotherapy pattern determined by the practitioner and in line with clinic protocols.
  • Distribute the product evenly throughout the treatment area to promote uniform hydration and tissue stimulation, taking care to avoid intravascular injection.
  • Typical treatment regimens consist of a series of sessions spaced several weeks apart (for example every 3–4 weeks), with the number of sessions and intervals tailored to the patient’s skin condition and desired outcome.
  • Following each session, provide post-procedure advice, such as avoiding intense heat, saunas, sun exposure, alcohol or vigorous exercise for a recommended time period, and using broad-spectrum sunscreen on exposed areas.
  • Advise the patient not to massage or manipulate the treated areas unless specifically instructed by the practitioner.
  • Dispose of all used syringes, needles and any remaining product as clinical sharps waste immediately after use; the product is strictly single-use per syringe and must not be reused or resterilised.
  • Self-administration by patients is not permitted and is strongly contraindicated.

Contraindications

  • Known hypersensitivity or allergy to polynucleotides, hyaluronic acid or any excipients in the formulation.
  • Active skin infections, inflammatory skin diseases or lesions (e.g. active herpes, dermatitis, cellulitis) at or near the intended injection sites.
  • Pregnancy or breastfeeding, as a precaution for elective aesthetic injectable procedures.
  • History of severe allergic reactions or anaphylaxis to injectable aesthetic products or similar biorevitalisation treatments.
  • Uncontrolled autoimmune disorders or significant systemic disease where injectable regenerative treatments may be inappropriate unless carefully evaluated and cleared by a physician.
  • Coagulation disorders or current use of anticoagulant or antiplatelet therapy that may increase the risk of bleeding or bruising, unless the risk–benefit balance is assessed and managed by the treating clinician.
  • Any general contraindication to intradermal injections or mesotherapy-type procedures as determined by a qualified healthcare professional.

Adverse Effects

  • Transient injection-site reactions such as redness, swelling, tenderness, warmth, itching or mild discomfort, typically resolving within a few hours to several days.
  • Local bruising or haematoma formation associated with needle or cannula insertion.
  • Temporary papules, nodules or unevenness in the treated area, generally improving as the product integrates and post-injection oedema subsides.
  • Rare inflammatory or hypersensitivity reactions including prolonged swelling, induration or local inflammatory nodules.
  • Very rare risk of infection at injection sites if aseptic technique is not strictly followed.
  • As with other injectable aesthetic procedures, inadvertent intravascular injection or injection into high-risk anatomical zones may lead to serious complications; procedures must therefore be carried out only by appropriately trained professionals familiar with facial anatomy and complication management.
  • Patients should be instructed to seek prompt medical review if they experience severe pain, excessive or progressive swelling, discolouration, visual disturbances or other unexpected symptoms after treatment.

Storage Conditions

  • Store in accordance with the temperature range specified on the outer packaging, typically at controlled room temperature; do not freeze.
  • Keep syringes in their original sterile blister and outer carton to protect from light and physical damage until use.
  • Do not use after the expiry date printed on the packaging.
  • Do not use if the packaging, blister or syringe appears damaged, opened or shows any sign of compromised sterility.
  • Keep out of the reach of children and unauthorised persons in a secure clinical storage area.
  • Once opened and used for a procedure, any remaining product must be discarded; do not store or reuse partially used syringes.

Duration

Usually administered as a course of multiple sessions (commonly 2\u20134 sessions at intervals of several weeks), with the exact number and spacing determined by the treating clinician based on individual skin needs and treatment goals. Clinical improvements in hydration, texture and radiance may persist for several months, after which maintenance sessions can be performed periodically according to professional judgement and patient response.

Onset

Early improvements in hydration and radiance may be noticeable within days to a few weeks after treatment, with progressive enhancement of skin texture, tone and elasticity over subsequent weeks as dermal regeneration and collagen support are stimulated and as the full treatment course is completed.

Browse more Medical Device

Top Treatments

Top Cities in the UK